____________________________
United States Anti-Doping Agency
5555 Tech Center Drive, Suite 200, Colorado Springs, CO 80919
■
Tel: 719.785.2000
■
Fax: 719.785.2001usada@usada.org
■
www.usada.org
REPORT ON PROCEEDINGS UNDER THE WORLD ANTI-DOPING CODEAND THE USADA PROTOCOL
U
NITED
S
TATES
A
NTI
-D
OPING
A
GENCY
,Claimant,v.L
ANCE
A
RMSTRONG
,Respondent.
REASONED DECISION OF THE UNITED STATES ANTI-DOPING AGENCYON DISQUALIFICATION AND INELIGIBILITY
TABLE OF CONTENTS
I.
SUMMARY OF USADA’S REASONED DECISION…………………………………………….5II.
CHARGES AGAINST LANCE ARMSTRONG…………………………………………………...7III.
BACKGROUND…………………………………………………………………………………… 9A.
Commencement of USADA’s Broad Investigation of Doping in Cycling……………………...9B.
Criminal Investigation…………………………………………………………………………. 11C.
USADA’s Notice of Anti-Doping Review Board Proceedings and Notice of Opportunity toContest USADA’s Charges in Arbitration……………………………………………………...11D.
Armstrong’s Filing of Federal Lawsuit…………………………………………………………12E.
Federal Court’s Order Dismissing Armstrong Lawsuit…………………………………………13F.
Armstrong’s Refusal to Contest Charges Against Him in Arbitration Hearing Before NeutralArbitrators……………………………………………………………………………………….13IV.
DISCUSSION OF THE EVIDENCE SUPPORTING USADA’S CHARGES………………...15A.
Introduction……………………………………………………………………………………..151.
Standard of Proof……………………………………………………………………………152.
Means of Proof: Non-Analytical Evidence and Laboratory Evidence……………………..15B.
Chronological Review of Evidence of Lance Armstrong’s Possession, Use, Trafficking andAdministration of Banned Performance Enhancing Drugs and Other Relevant Events……..161.
1998…………………………………………………………………………………………16a.
Possession and use of EPO at the Vuelta a España…………………………………….18b.
Possession and use of cortisone………………………………………………………..19c.
Use of a saline infusion at the World Championships…………………………………202.
1999………………………………………………………………………………………..20a.
Focus on the Tour de France…………………………………………………………...21b.
The “A” Team………………………………………………………………………….22c.
Getting serious with Dr. Ferrari………………………………………………………..23d.
U.S. Postal drug delivery system………………………………………………………28e.
Possession and use of EPO……………………………………………………………..29f.
Motoman and the plan to deliver EPO at the Tour de France………………………….30g.
The Tour de France…………………………………………………………………….31h.
Positive for cortisone…………………………………………………………………..31i.
EPO use at the Tour de France…………………………………………………………33 j.
Testosterone use and administration at the Tour de France……………………………34k.
Sestriéres……………………………………………………………………………….34l.
Christophe Bassons…………………………………………………………………….35m. Seven witnesses and scientific corroboration…………………………………………363.
2000………………………………………………………………………………………..37a.
Armstrong’s involvement in the U.S. Postal Service blood doping program…………38b.
Armstrong’s use of testosterone and avoiding drug testing at race in Spain ………….39c.
Armstrong’s second Tour victory……………………………………………………...40d.
Blood doping at the 2000 Tour de France……………………………………………...41e.
French investigation and “Actovegin”………………………………………………….424.
2001………………………………………………………………………………………..45a.
Ferrari attends USPS training camp……………………………………………………46b.
Armstrong’s continued involvement in blood doping in 2001………………………...49
ii
c.
Armstrong’s possession, use and trafficking of EPO in 2001…………………………49d.
Armstrong’s suspicious test for EPO at the 2001 Tour of Switzerland………………..51e.
Armstrong’s possession and use of testosterone in 2001………………………………52f.
Controversy concerning Armstrong’s relationship with Ferrari and Italian lawenforcement investigation of Ferrari…………………………………………………...535.
2002………………………………………………………………………………………...54a.
Floyd Landis……………………………………………………………………………54b.
Landis begins working with Ferrari……………………………………………………57c.
Armstrong’s possession, use and trafficking of testosterone in 2002………………….58d.
Armstrong’s continued use of blood doping in 2002…………………………………..58e.
Armstrong’s enforcement of the team doping program………………………………..596.
2003.……………………………………………………………………………………......60a.
Armstrong’s continued use of blood doping in 2003…………………………………..61b.
Armstrong’s blood doping and EPO use at the 2003 Tour de France………………….63c.
Armstrong gets help from Tyler Hamilton……………………………………………..64d.
Armstrong’s possession, use and trafficking or administration of EPO and/ortestosterone in 2003…………………………………………………………………….657.
2004………………………………………………………………………………………...67a.
Armstrong continues to work with Ferrari in 2004…………………………………….68b.
Armstrong’s use of testosterone in 2004……………………………………………….69c.
Armstrong’s blood doping and EPO use at the 2004 Tour de France………………….70d.
Armstrong’s altercation with Filippo Simeoni at the 2004 Tour………………………72e.
Dr. Ferrari’s October 1, 2004, conviction for sporting fraud and Armstrong’s publictermination of professional relationship with Ferrari…………………………………..738.
2005………………………………………………………………………………………...75a.
Armstrong’s use of blood transfusions in 2005..………………………………………75b.
Possession, use and administration of EPO……………………………………………76c.
Hincapie’s post Tour drug sweep of Armstrong’s apartment………………………….76d.
Ferrari fabrication………………………………………………………………………77e.
SCA Testimony of Bill Stapleton and Lance Armstrong regarding Dr. Ferrari……….799.
2009 – 2012………………………………………………………………………………..82a.
Continuing Ferrari fabrication…………………………………………………………82b.
Evidence of blood doping……………………………………………………………...8610.
Weight to be given to Lance Armstrong’s refusal to testify……………………………….87C.
Overwhelming Proof that Lance Armstrong’s Support Staff Participated in Doping………….881.
Dr. Michele Ferrari’s involvement in doping……………………………………………...902.
Johan Bruyneel’s involvement in doping…………………………………………………1073.
Dr. Luis Garcia del Moral’s involvement in doping……………………………………...1154.
Dr. Pedro Celaya’s involvement in doping……………………………………………….1185.
Jose “Pepe” Marti’s involvement in doping………………………………………………123D.
Consideration of the Credibility and Reliability of USADA’s Fact Witnesses……………….127E.
How Lance Armstrong and the USPS Team Avoided Positive Drug Tests..............................1291.
Avoiding testers during window of detection….................................................................1312.
Using undetectable substances and methods…..................................................................1353.
Understanding limitations to the testing methods…...........................................................1374.
Use of saline infusions and micro-doping of EPO…..........................................................139
Search History:
Result 00 of 00
00 results for result for
p.
Reasoned Decision
196.1K
Reads
103
Readcasts
861.9K
Embed Views
Get Scribd Mobile
To get Scribd mobile enter your number and we'll send you a link to the Scribd app for iPhone & Android.We've sent a link to the Scribd app. If you didn't receive it, try again.
We'll never share your phone number.
Recommended
More From This User
Notes
Load more
